Table 2.
Outcome and mortality rates with regard to HTLV status, irrespective of HIV-status. Individuals from the same cohorts as in table 1 are included, but with an HTLV-1 result from any previous survey
| Negative | HTLV-I | Total | |||
| Men | Women | Men | Women | All | |
| Previous HTLV result from 1990 or 1996. | 497 | 550 | 20 | 57 | 1,124 |
| Total re-identified with a previous HTLV result | 496 | 550 | 20 | 57 | 1,123 |
| Confusion/age uncertain | 4/0 | 5/0 | 0/0 | 2/0 | 11 |
| Exit study at age <35. | 21 | 16 | 0 | 0 | 37 |
| Total participating in analysis: | 471 | 529 | 20 | 55 | 1,075 |
| Moved (%*) | 75 (15.9) | 80(15.1) | 3 (15%) | 4 (7.3) | 162 (15.1) |
| Died (%*) | 79 (16.8) | 69 (13.0) | 7 (35%) | 15 (27.2) | 170 (15.8) |
| Median follow-up time in years (range) | 2.9 (0.0–9.1) | 2.9 (0.0–10.5) | 3.0 (0.8–7.8) | 3.4 (0.8–9.4) | 3.0 (0.0–10.5) |
| Total follow-up time in years | 1703 | 2004 | 73.4 | 242 | 4022 |
| Mortality rate/1000 pyo (95%CI†) | 46.4 (37.2, 57.8) | 34.4 (27.2 43.6) | 95.4 (45.5, 200) | 61.9 (37.8, 103) | 42.3 (36.4, 49.1) |
*% of total number participating.
† CI = confidence interval